HC010

DRUG4 trials

Sponsors

HC Biopharma Inc.

Conditions

Advanced Solid TumorAdvanced Solid Tumor CancerNSCLC

Phase 1

A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors

RecruitingNCT06307925

HC Biopharma Inc.Advanced Solid Tumor

Start: 2024-03-27End: 2025-12-31Target: 122Updated: 2025-05-13

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer

RecruitingNCT07381829

HC Biopharma Inc.Advanced Solid Tumor Cancer

Start: 2025-10-27End: 2026-12-30Target: 328Updated: 2026-02-02

A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors

RecruitingNCT07477743

HC Biopharma Inc.Advanced Solid Tumor Cancer

Start: 2026-03-17End: 2028-03-31Target: 331Updated: 2026-03-17

Phase 2

HC010 in First-line PD-L1 Positive Advanced NSCLC Patients

RecruitingNCT07169552

HC Biopharma Inc.NSCLC

Start: 2025-12-09End: 2027-09-30Target: 50Updated: 2025-12-17